Kanagawa, Japan

Kyoko Toyofuku

This inventor holds 2 USPTO granted patents. Top assignees: Takeda Pharmaceutical Company Limied, Takeda Pharmaceutical Company Limited. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyoko Toyofuku. Retrieved from https://idiyas.com/inventor/kyoko-toyofuku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kyoko Toyofuku: Innovator in Pharmaceutical Compounds

Introduction

Kyoko Toyofuku is a notable inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Kyoko Toyofuku holds 2 patents. Her latest patents include a bicyclic compound, which is represented by a specific formula, and an aromatic ring compound that exhibits glucagon antagonistic action. The latter is particularly useful for the prophylaxis or treatment of diabetes and similar conditions.

Career Highlights

Throughout her career, Kyoko has worked with prominent organizations, including Takeda Pharmaceutical Company Limited. Her work has focused on innovative solutions that address critical health issues.

Collaborations

Kyoko has collaborated with esteemed colleagues such as Tohru Yamashita and Takuya Fujimoto, contributing to a dynamic research environment.

Conclusion

Kyoko Toyofuku's contributions to pharmaceutical innovations highlight her role as a leading inventor in her field. Her work continues to impact the development of treatments for diabetes and other health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…